Chlamydia trachomatis
Morphology |
Microaerobic, non-spore forming, gram-negative bacteria. They form motile, spiral
shaped rods Nonmotile, gram negative, obligate intracellular pathogen that is around
0.3-1 µm in diameter.
|
---|---|
Disease |
Ocular trachoma: acute inflammation of the epithelium of the eye. Lymphogranuloma venereum (LGV): genital ulcers followed by lymphadenophathy. |
Zoonosis |
None.
|
Host Range |
Human.
|
---|---|
Modes of Transmission |
Close contact with infected individuals, fomites, and flies. Vaginal, anal or oral
sexual contact, or during passage through the birth canal.
|
Signs and Symptoms |
Chills, headache, myaglias, and arthralgias. Infection can further spread into the
eyes, central nervous system, heart and lungs. Pelvic pain, burning urination, and
abnormal vaginal bleeding, with inflammation of the endocervical columnar epithelium.
|
Infectious Dose | Unknown. |
Incubation Period |
7-14 days for trachoma and genital infections, 3-30 days for LGV.
|
Prophylaxis | None. |
---|---|
Vaccines | None. |
Treatment |
Azithromycin, doxycycline, or topical tetracycline.
|
Surveillance | Monitor for symptoms. |
MSU Requirements | Report any exposures |
Laboratory Acquired Infections (LAIs) | Have been reported.
|
---|---|
Sources |
Genital, bubo and conjunctival fluids, cultures, frozen stocks, other samples described
in IBC protocol.
|
BMBL:
|
https://www.cdc.gov/labs/BMBL.html |
---|---|
Canada PSDS:
|
|
NIH Guidelines:
|
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures involving infected animals
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection |
1% sodium hypochlorite, 70 % ethanol, 0.5% glutaraldehyde, iodines, and formaldehyde
|
---|---|
Inactivation |
Inactivated by moist heat (60 minutes at 121oC), dry heat (1 hour at 160-170oC).
|
Survival Outside Host |
Can survive on surfaces for 2-3 hours under humid conditions.
|
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |